About Irritable Bowel Syndrome
Irritable bowel syndrome is a common disorder of the digestive system causing abdominal cramps, discomfort, bloating, constipation, and diarrhea. Inflammatory bowel disease, which is a chronic disease with recurrent immune response and inflammation of the GI tract, is sometimes confused with irritable bowel syndrome. The symptoms of irritable bowel syndrome generally appear in a patient aged around 30 years. According to the CDC, prominent symptoms of irritable bowel syndrome include severe bloating, severe stomach cramps or abdominal pain, lower back pain, groin pain, heartburn, acidity, shooting pain in the legs, and lightheadedness after eating.

TechNavio’s analysts forecast the Global Irritable Bowel Syndrome market to grow at a CAGR of 14.04 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Irritable Bowel Syndrome market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of irritable bowel syndrome.
TechNavio’s report, Global Irritable Bowel Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Irritable Bowel Syndrome market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

心的外傷後ストレス障害（PTSD）治療薬の世界市場：抗うつ薬、抗不安薬 IRTNTR6225 / Technavio / 2015年6月24日 / 当調査レポートでは、心的外傷後ストレス障害（PTSD）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、心的外傷後ストレス障害（PTSD）治療薬の世界市場規模及び予測、製品パイプライン分析、治療薬種類別分析、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About PTSD PTSD is a psychological condition that develops after a person is exposed to any traumatic event, and it drains a person emotionally. According to the DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association (APA), PTSD is classified under anxiety disorders. PTSD can occur in individuals of any age, irrespective of the gender; its symptoms can develop immediately after a traumatic event or during the course of time. Its symptoms normally include re-experience of the traumatic event, avoidance of the incidents, and abnormal mood swings. Treatments for PTSD include...

全身性エリテマトーデス（SLE）治療薬の世界市場 IRTNTR5703 / Technavio / 2015年4月22日 / 当調査レポートでは、全身性エリテマトーデス（SLE）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、全身性エリテマトーデス（SLE）治療薬の世界市場規模及び予測、治療クラス別分析、種類別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About SLE SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of flare-ups and remissions and can range from mild to life threatening...

炎症性腸疾患（IBD）治療薬の世界市場：クローン病、潰瘍性大腸炎 IRTNTR5692 / Technavio / 2015年4月15日 / 当調査レポートでは、炎症性腸疾患（IBD）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、パイプライン動向、炎症性腸疾患（IBD）治療薬の世界市場規模及び予測、種類別分析、投与経路（ROA）別分析、市場シェア、地域別分析、主要国別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Inflammatory Bowel Disease Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss. Inflammatory bowel disease can also prove to be life-threatening for the patients. Ulcerative colitis generally affects the colon, where inflammation and ulcers develop in the innermost lining of the colon and the rectum of a patient. Crohn's disease causes inflammation of...

変形性膝関節症（Osteoarthritis）治療薬の世界市場 IRTNTR5334 / Technavio / 2015年3月18日 / 当調査レポートでは、変形性膝関節症（Osteoarthritis）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、変形性膝関節症（Osteoarthritis）治療薬の世界市場規模及び予測、市場シェア、地域別分析、パイプライン分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About OA OA is a condition in which the cartilage, a material that cushions the joints, breaks down. This leads to stiffness, inflammation, pain, and loss of joint movement. The exact etiology of OA is not fully understood. Obesity, overuse of the joint, weak thigh muscles, aging, and genetics are some of the common risk factors of OA; OA symptoms usually develop progressively. At first, there may be stiffness that appears to be more a niggle than a medical concern. Treatment is given depending on the affected joint, including the hand, wrist, neck, back, knee, and hip, and involves medication...

嚢胞性線維症（CF症）治療薬の世界市場 IRTNTR4842 / Technavio / 2014年12月17日 / 当調査レポートでは、嚢胞性線維症（CF症）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、嚢胞性線維症（CF症）治療薬の世界市場規模及び予測、投与経路（ROA）別分析、市場シェア、地域別分析、主要国別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Cystic Fibrosis Cystic fibrosis also known as mucoviscidosis is a genetically-inherited disease. It is one of the most common genetic disorders found in the Caucasian children. The incidence of cystic fibrosis varies among populations, and is substantially less common in Asian and African populations as compared to the people of Caucasoid origin of Europe and North America, with a marked difference within each country. Cystic fibrosis is a chronic disease. The production of a high-salt containing sweat and secretion of abnormal viscous mucus are the major symptoms of cystic fibrosis. TechNavio's analysts forecast the Global Cystic Fibrosis market to...

統合失調症（Schizophrenia）治療薬の世界市場 IRTNTR4716 / Technavio / 2014年11月19日 / 当調査レポートでは、統合失調症（Schizophrenia）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、統合失調症（Schizophrenia）治療薬の世界市場規模及び予測、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Schizophrenia Schizophrenia is a chronic brain disorder that severely affects the quality of life of a patient by disturbing the normal functioning of the brain. Psychotic symptoms and a diminished range of expression of emotions are the characteristics of schizophrenia. The exact etiology of schizophrenia is still not known. In men, it appears in the late teens or early 20s, and in women in the late 20s or early 30s. However, most of the symptoms of this disorder can be managed with medication and psychological help. TechNavio's analysts forecast the Global Schizophrenia Therapeutics market to grow at a CAGR...

クッシング症候群（Cushing’s Syndrome）治療薬の世界市場：コルチコイド受容体拮抗薬、ソマトスタチン類縁体、コルチゾール合成阻害剤 IRTNTR4695 / Technavio / 2014年11月12日 / 当調査レポートでは、クッシング症候群（Cushing's Syndrome）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、クッシング症候群（Cushing's Syndrome）治療薬の世界市場規模及び予測、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Cushing's Syndrome Cushing's syndrome is a condition caused by the prolonged exposure to very high levels of cortisol. This can occur because of the consumption of glucocorticoid drugs or diseases that result in excess cortisol, ACTH, and CRH secretion. Harvey Cushing described the pathophysiology of this condition in 1932. It is more common in women than in men. Cushing's syndrome is also known as hypercortisolism, hypercorticism, hyperadrenocorticism, or Itsenko-Cushing syndrome. Some of the common symptoms of Cushing's syndrome are increase in weight, facial acne, cognitive disorders, and vulnerability to superficial fungus infections, growth of a mass around the collarbone...

過活動膀胱（OAB）治療薬の世界市場：抗ムスカリン剤、ß3アドレナリン受容体作動薬 IRTNTR4514 / TechNavio / 2014年11月5日 / ...About Overactive Bladder Overactive bladder is a urological condition associated with urination problems. The condition is characterized by bladder storage symptoms such as urgency, change in frequency of urination, nocturia, or urinary incontinence. It is also known as overactive bladder syndrome. Although it is not a life-threatening condition, it is often stigmatized and debilitating. Some of the important symptoms of overactive bladder are urinary urgency and incontinence. The pathophysiology of overactive bladder is not characterized completely. The symptoms of overactive bladder can last for a lifetime or it can relapse and remit. The problem can be resolved through treatment. Overactive...

痤瘡（Acne）治療薬の世界市場 IRTNTR4570 / TechNavio / 2014年11月5日 / ...About Acne Acne is one of the common dermatological disorders. Acne, or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is not fully understood. Although acne does not present a serious threat to health, severe acne can not only be painful, but also affect a patient’s quality of life. Topical medications, oral medications, or a combination of all are some of the treatment options available for acne. TechNavio's analysts forecast the Global Acne market to grow at a CAGR of 4.07 percent over the period 2013-2018....

発達障害（ADHD）治療薬の世界市場：中枢刺激薬、非中枢刺激薬 IRTNTR4390 / Technavio / 2014年10月22日 / ...About ADHD ADHD is a psychiatric disorder, which is mostly found in children. However, adults have also been reported to be diagnosed with ADHD. The patients with ADHD suffer from several problems including hyperactivity, impulsiveness, and lack of focus and concentration. The causes of ADHD are not known. It is believed to be linked with genetic and environmental causes. However, it has been reported to be related with the decrease in the extraneuronal levels of norepinephrine and dopamine. In addition, the patients have an abnormality in the brain structure. It is more prevalent in boys than girls. The management of...